Merck & Co Inc (NYSE:MRK)

90.97
Delayed Data
As of Jan 17
 -0.21 / -0.23%
Today’s Change
72.05
Today|||52-Week Range
92.64
+0.02%
Year-to-Date
Here's Why Clovis Oncology Rose as Much as 25.6% Today
Jan 15 / MotleyFool.com - Paid Partner Content
The Risk of Cancer-Related Death Is Dropping Faster Than Ever
Jan 08 / MotleyFool.com - Paid Partner Content
FDA Gives Clovis Oncology's Rubraca a Priority Review
Jan 15 / MotleyFool.com - Paid Partner Content
Dollar Tree Stock Is Down 20%, But Investors Should Reject Mini-Tender Offer
Jan 08 / MotleyFool.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Merck
Jan 15 / MotleyFool.com - Paid Partner Content
Merck's Keytruda Misses an Important Lung Cancer Goal
Jan 07 / MotleyFool.com - Paid Partner Content
Merck's Blockbuster Drug Wins Key New FDA Approval
Jan 08 / MotleyFool.com - Paid Partner Content
Is Johnson & Johnson Stock a Buy?
Jan 05 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close91.18
Today’s open91.28
Day’s range90.86 - 91.63
Volume9,667,383
Average volume (3 months)8,252,565
Market cap--
Data as of 6:30pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+165.32%
Earnings growth (this year)+18.88%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.17%
P/E ratio25.4
Price/Sales4.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.10-0.25%
NVSNovartis+0.83+0.87%
BMYBristol-Myers Squibb-0.06-0.09%
AZNAstraZeneca+0.82+1.62%
Data as of 6:30pm ET, 01/17/2020

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$1.15
Annual revenue (last year)$42.4B
Annual profit (last year)$6.2B
Net profit margin14.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts